期刊
PEDIATRICS
卷 129, 期 5, 页码 E1343-E1347出版社
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2011-2538
关键词
codeine; tonsillectomy; sleep apnea
类别
资金
- Canadian Pharmacogenomics Network for Drug Safety (CPNDS)
- Canadian Institutes for Health Research (CIHR)
- Pfizer Canada
In 2009 we reported the fatal case of a toddler who had received codeine after adenotonsillectomy for obstructive sleep apnea syndrome. The child was an ultra-rapid metabolizer of cytochrome P4502D6 (CYP2D6). We now report 3 additional fatal or life-threatening cases from North America. In the 2 fatal cases, functional gene duplications encoding for CYP2D6 caused a significantly greater production of potent morphine from its parent drug, codeine. A severe case of respiratory depression in an extensive metabolizer is also noted. These cases demonstrate that analgesia with codeine or other opioids that use the CYP2D6 pathway after adenotonsillectomy may not be safe in young children with obstructive sleep apnea syndrome. Pediatrics 2012;129:e1343-e1347
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据